22nd Century Group Welcomes Dr. Califf as FDA Commissioner, Urges Action on Menthol and Nicotine in Combustible Cigarettes
February 25, 2022 09:51 ET
|
22nd Century Group, Inc
FDA’s Rulemaking Process Could Make VLN® Menthol King Reduced Nicotine Cigarettes the Only Menthol Cigarette on the Market Opportunity to Accelerate FDA’s Plan to Cap Nicotine in Cigarettes at Levels...
22nd Century and KeyGene Achieve Breakthrough in Hemp/Cannabis Plant Transformation
February 23, 2022 08:00 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Feb. 23, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Secures USDA Organic Certification for Needle Rock Farms
February 10, 2022 11:30 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Feb. 10, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group to Announce Fourth Quarter and Full Year 2021 Results on March 1, 2022
February 03, 2022 09:20 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Feb. 03, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group Supports Upcoming FDA Action Banning Menthol in Highly Addictive Combustible Cigarettes
February 01, 2022 12:30 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Feb. 01, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group Announces First Production of VLN® Cigarettes for Retail Sale
January 26, 2022 11:00 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Jan. 26, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
22nd Century Group Appoints James A. Mish to Its Board of Directors
January 21, 2022 08:00 ET
|
22nd Century Group, Inc
BUFFALO, N.Y, Jan. 21, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and...
22nd Century Launching the First Reduced Nicotine Cigarette Authorized by the FDA That Helps You Smoke Less
January 18, 2022 08:00 ET
|
22nd Century Group, Inc
FDA Mandates Addition of Extra Claim “Helps You Smoke Less” on PackagingU.S. Pilot Market Launch with Major Retail Partner by March 2022 BUFFALO, N.Y., Jan. 18, 2022 (GLOBE NEWSWIRE) -- On December...
22nd Century Group to Participate in Fireside Chat Events with Alliance Global Partners Equity Analyst Aaron Grey and Cowen Equity Analyst Vivien Azer on Wednesday, January 5, 2022
January 03, 2022 14:23 ET
|
22nd Century Group, Inc
BUFFALO, N.Y., Jan. 03, 2022 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco,...
FDA อนุญาตให้การทำตลาด VLN® ของ 22nd Century Group ในฐานะผลิตภัณฑ์ยาสูบปรับลดความเสี่ยง
December 29, 2021 06:31 ET
|
22nd Century Group, Inc
VLN® เป็นบุหรี่ชนิดที่เผาไหม้รายแรกและรายเดียวของโลกที่ได้รับการรับรองจาก FDA MRTPFDA เพิ่มการอ้างสิทธิ์ตามหัวข้อข่าวว่า “ช่วยให้คุณสูบบุหรี่น้อยลง”...